Stock Watch: New Year, New Politics; Same Old Pricing And Generic Challenges
And Amarin Rallies Despite Unpromising Prospects
A positive start to the year for healthcare stocks was accompanied, as usual, by drug price increases. This and the other issues that have been carried over from 2020 remain just as challenging.
